Prolonged survival with longer duration of maintenance lenalidomide after autologous hematopoietic stem cell transplantation for multiple myeloma

BACKGROUND: Though lenalidomide maintenance therapy has demonstrated improved outcomes after autologous hematopoietic stem cell transplantation (auto-HCT) in patients with multiple myeloma (MM), the impact of the duration of this therapy is not clearly known. PATIENTS AND METHODS: We retrospectively...

全面介紹

Na minha lista:
書目詳細資料
發表在:Cancer
Main Authors: Mian, Idrees, Milton, Denái R., Shah, Nina, Nieto, Yago, Popat, Uday R., Kebriaei, Partow, Parmar, Simrit, Oran, Betul, Shah, Jatin J., Manasanch, Elisabet E., Orlowski, Robert Z., Shpall, Elizabeth J., Champlin, Richard E., Qazilbash, Muzaffar H., Bashir, Qaiser
格式: Artigo
語言:Inglês
出版: 2016
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5138119/
https://ncbi.nlm.nih.gov/pubmed/27680710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30366
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍